Chiara Ippolito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chiara Ippolito has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Antonino Cattaneo
Laboratorio di Biologia BIO@SNS, Scuola Normale Superiore, Pisa, Italy
1 shared publication - Cristina Di Primio
Italian National Research Council (CNR) Institute of Neuroscience Pisa Italy
1 shared publication - Giacomo Siano
Italian National Research Council (CNR) Institute of Neuroscience Pisa Italy
1 shared publication - Marco Mainardi
Department of Biomedical Sciences, University of Padua (DSB), Padua, Italy
1 shared publication - Maria Claudia Caiazza
Scuola Normale Superiore
1 shared publication - Martina Varisco
Scuola Normale Superiore
1 shared publication
Latest Publications
- Open Access
Nuclear Tau modulates VGluT1 expression: a new function for Tau
Summary Tau displacement from microtubules is the first step in the onset of tauopathies, and is followed by toxic protein aggregation. However, other non-canonical functions of Tau might have a role in these pathologies. Here, we demonstrate that a small amount of Tau localizes in the nuclear compartment and accumulates in both the soluble and DNA-bound fractions. We show that nuclear Tau regulates the expression of VGluT1, a disease-relevant gene directly involved in glutamatergic synaptic transmission. Impeding Tau/tubulin interaction in the cytosol favours its nuclear translocation and increases VGluT1 expression. Remarkably, the P301L mutation impairs this mechanism leading to a loss of function. Altogether, our results provide the demonstration of a direct physiological role of Tau on gene expression. Alterations of this mechanism may be at the basis of the onset of neurodegeneration.
Open AccessNuclear Tau modulates VGluT1 expression: a new function for Tau
Summary Tau displacement from microtubules is the first step in the onset of tauopathies, and is followed by toxic protein aggregation. However, other non-canonical functions of Tau might have a role in these pathologies. Here, we demonstrate that a small amount of Tau localizes in the nuclear compartment and accumulates in both the soluble and DNA-bound fractions. We show that nuclear Tau regulates the expression of VGluT1, a disease-relevant gene directly involved in glutamatergic synaptic transmission. Impeding Tau/tubulin interaction in the cytosol favours its nuclear translocation and increases VGluT1 expression. Remarkably, the P301L mutation impairs this mechanism leading to a loss of function. Altogether, our results provide the demonstration of a direct physiological role of Tau on gene expression. Alterations of this mechanism may be at the basis of the onset of neurodegeneration.